Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinityCamilo Ayala Breton, Nitwara Wikan, Arinda Abbuhl, et al.
Molecular Cancer Therapeutics|August 28, 2020
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune PatientsEugene S Bah, Rebecca A Nace, Kah Whye Peng, et al.
Molecular Therapy Oncolytics|January 1, 2020
Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus InfectionLianwen Zhang, Lukkana Suksanpaisan, Huailei Jiang, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
Human Gene Therapy. Clinical Development|May 19, 2017
Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSVLauro Velazquez-Salinas, Shruthi Naik, Steven J Pauszek, et al.
Current Cancer Drug Targets|February 24, 2017
Clinical Trials with Oncolytic Measles Virus: Current Status and Future ProspectsPavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, et al.
Plos One|January 12, 2012
Long-term infection and vertical transmission of a gammaretrovirus in a foreign host speciesToshie Sakuma, Jason M Tonne, Jessica A Malcolm, et al.
Human Gene Therapy|December 19, 2009
International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, IrelandBarbara Guinn, Garrett Casey, Mecker G Möller, et al.
Molecular Therapy. Oncology|June 17, 2026
Endothelial injury is a central driver of systemic IFN-β toxicity and is reversible through Jak inhibitionLianwen Zhang, Linh Pham, Michael B Steele, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivoHooi Tin Ong, Theodore R Trejo, Linh D Pham, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinityCamilo Ayala Breton, Nitwara Wikan, Arinda Abbuhl, et al.
Molecular Cancer Therapeutics|August 28, 2020
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune PatientsEugene S Bah, Rebecca A Nace, Kah Whye Peng, et al.
Molecular Therapy Oncolytics|January 1, 2020
Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus InfectionLianwen Zhang, Lukkana Suksanpaisan, Huailei Jiang, et al.
Cancer Research|August 17, 2002
Intraperitoneal therapy of ovarian cancer using an engineered measles virusKah-Whye Peng, Cynthia J TenEyck, Evanthia Galanis, et al.
Human Gene Therapy. Clinical Development|May 19, 2017
Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSVLauro Velazquez-Salinas, Shruthi Naik, Steven J Pauszek, et al.
Current Cancer Drug Targets|February 24, 2017
Clinical Trials with Oncolytic Measles Virus: Current Status and Future ProspectsPavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, et al.
Plos One|January 12, 2012
Long-term infection and vertical transmission of a gammaretrovirus in a foreign host speciesToshie Sakuma, Jason M Tonne, Jessica A Malcolm, et al.
Human Gene Therapy|December 19, 2009
International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, IrelandBarbara Guinn, Garrett Casey, Mecker G Möller, et al.
Molecular Therapy. Oncology|June 17, 2026
Endothelial injury is a central driver of systemic IFN-β toxicity and is reversible through Jak inhibitionLianwen Zhang, Linh Pham, Michael B Steele, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivoHooi Tin Ong, Theodore R Trejo, Linh D Pham, et al.
Pageof 12